As Elbarto suggested if the plasma concentrations were a concern they could have kept ascending, they could have done additional phase 1 trials with longer/slower dosing or a whole range of strategies. The Recce scientists are alot more knowledgeable about 327 and biochemistry then we are and chose to progress the trials; I think people should just zip up and wait.
Regarding the insinuation about integrity. Let's not forget 'they' have alot more to lose than we do. This is a families legacy, they are heavily invested and the stock has been beaten and needs another raise soon, they have alot of incentive to make wise and decent choices.
RCE Price at posting:
65.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)